Skip to Content

Cancers, Volume 13, Issue 24

2021 December-2 - 242 articles

Cover Story: Melanoma is the least common but deadliest type of skin cancer. It is driven by mutations and epigenetic alterations in oncogenes and tumor suppressor genes. Epigenetic alterations lead to immune evasion and resistance to therapies. Melanoma treatments include surgery, targeted therapies and immune checkpoint blockade (ICB), which improve the survival of a small subset of patients. Thus, there is an urgent need to identify alternative combination therapies. Due to the susceptibility to extrinsic factors and reversible nature of melanoma, epigenetic drugs are investigated as a therapeutic avenue and as adjuvants for targeted therapies and ICB. Preclinical and clinical research studies on epigenetic drugs, such as HDAC and DNMT inhibitors, have shown the mechanisms by which these drugs can prevent resistance or enhance the therapeutic efficacy of current treatments for melanoma patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (242)

  • Article
  • Open Access
16 Citations
3,911 Views
11 Pages

Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders

  • Luca Ielasi,
  • Francesco Tovoli,
  • Matteo Tonnini,
  • Raffaella Tortora and ,
  • Giulia Magini,
  • Rodolfo Sacco,
  • Tiziana Pressiani,
  • Franco Trevisani,
  • Vito Sansone and
  • Alessandro Granito
  • + 7 authors+ 2 authors

20 December 2021

Case–control observational studies suggested that aspirin might prevent hepatocellular carcinoma (HCC) in high-risk patients, even if randomized clinical trials are lacking. Information regarding aspirin in subjects who already developed HCC, e...

(This article belongs to the Collection Treatment of Hepatocellular Carcinoma and Cholangiocarcinoma)
  • Article
  • Open Access
16 Citations
6,352 Views
27 Pages

Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells

  • Chhanda Bose,
  • Ashly Hindle,
  • Jihyun Lee,
  • Jonathan Kopel and ,
  • Sahil Tonk,
  • Philip T. Palade,
  • Sharad S. Singhal,
  • Sanjay Awasthi and
  • Sharda P. Singh
  • + 4 authors+ 0 author

20 December 2021

Her2-amplified breast cancers resistant to available Her2-targeted therapeutics continue to be a challenge in breast cancer therapy. Dox is the mainstay of chemotherapy of all types of breast cancer, but its usefulness is limited by cumulative cardio...

(This article belongs to the Special Issue p53 and Ralbp1 in Carcinogenesis)
  • Article
  • Open Access
5 Citations
4,064 Views
10 Pages

Identification of Lynch Syndrome Carriers among Patients with Small Bowel Adenocarcinoma

  • Ariadna Sánchez,
  • Luis Bujanda,
  • Miriam Cuatrecasas,
  • Alex Bofill and ,
  • Cristina Alvarez-Urturi,
  • Goretti Hernandez,
  • Lara Aguilera,
  • Sabela Carballal,
  • Joan Llach and
  • Leticia Moreira
  • + 16 authors+ 11 authors

20 December 2021

Background: Small bowel adenocarcinoma (SBA) is a rare disease which can be associated with Lynch syndrome (LS). LS tumors are characterized by the presence of microsatellite instability (MSI) and/or the loss of mismatch repair (MMR) protein expressi...

(This article belongs to the Special Issue Lynch Syndrome)
  • Article
  • Open Access
37 Citations
3,795 Views
13 Pages

A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network

  • Roberta Zanotti,
  • Massimiliano Bonifacio,
  • Cecilia Isolan,
  • Ilaria Tanasi and ,
  • Lara Crosera,
  • Francesco Olivieri,
  • Giovanni Orsolini,
  • Donatella Schena and
  • Patrizia Bonadonna
  • + 4 authors+ 0 author

20 December 2021

Systemic mastocytosis (SM) and other adult clonal mast cell disorders (CMD) are often underestimated, and their epidemiology data are scarce. We aimed at evaluating the impact of the activity of the Interdisciplinary Group for Study of Mastocytosis (...

(This article belongs to the Special Issue Pathogenesis and Natural History of Myeloproliferative Neoplasms)
  • Article
  • Open Access
9 Citations
3,715 Views
15 Pages

20 December 2021

Background: The incidence of lung cancer differs between men and women, suggesting the potential role of sex-specific influences in susceptibility to this cancer. While behavioural differences may account for some of the risk, another possibility is...

(This article belongs to the Special Issue Bioinformatics, Big Data and Cancer)
  • Article
  • Open Access
11 Citations
3,981 Views
15 Pages

Intraoperative HIFU Ablation of the Pancreas Using a Toroidal Transducer in a Porcine Model. The First Step towards a Clinical Treatment of Locally Advanced Pancreatic Cancer

  • Celia Cilleros,
  • Aurélien Dupré,
  • Yao Chen,
  • Jeremy Vincenot and ,
  • Michel Rivoire and
  • David Melodelima
  • + 1 author+ 0 author

20 December 2021

Apart from palliative chemotherapy, no other therapy has been proven effective for the treatment of locally advanced pancreatic tumors. In this study, an intraoperative high-intensity focused ultrasound (HIFU) device was tested in vivo to demonstrate...

(This article belongs to the Special Issue Ultrasound-Based Treatments of Cancer)
  • Hypothesis
  • Open Access
13 Citations
4,164 Views
19 Pages

hsa_circ_0001275 Is One of a Number of circRNAs Dysregulated in Enzalutamide Resistant Prostate Cancer and Confers Enzalutamide Resistance In Vitro

  • Marvin C. J. Lim,
  • Anne-Marie Baird,
  • John Greene,
  • Ciara McNevin and ,
  • Karine Ronan,
  • Petar Podlesniy,
  • Orla Sheils,
  • Steven G. Gray,
  • Ray S. McDermott and
  • Stephen P. Finn
  • + 5 authors+ 0 author

20 December 2021

Background: Enzalutamide is part of the treatment regimen for metastatic castration-resistant prostate cancer (MCRPC). However, both intrinsic and acquired resistance to the drug remain substantial clinical quandaries. circRNAs, a novel type of non-c...

(This article belongs to the Special Issue Circular RNAs: New Insights into the Molecular Biology of Cancer)
  • Review
  • Open Access
41 Citations
10,471 Views
34 Pages

PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

  • Clifford M. Csizmar,
  • Antoine N. Saliba,
  • Elizabeth M. Swisher and
  • Scott H. Kaufmann

20 December 2021

Despite recent discoveries and therapeutic advances in aggressive myeloid neoplasms, there remains a pressing need for improved therapies. For instance, in acute myeloid leukemia (AML), while most patients achieve a complete remission with convention...

(This article belongs to the Special Issue Clinical Use of PARP Inhibitors in Cancer – From Bench to Bedside and Back Again)
  • Article
  • Open Access
45 Citations
7,394 Views
32 Pages

Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel

  • Joaquim Carreras,
  • Shinichiro Hiraiwa,
  • Yara Yukie Kikuti,
  • Masashi Miyaoka and ,
  • Sakura Tomita,
  • Haruka Ikoma,
  • Atsushi Ito,
  • Yusuke Kondo,
  • Giovanna Roncador and
  • Naoya Nakamura
  • + 8 authors+ 3 authors

20 December 2021

Diffuse large B-cell lymphoma (DLBCL) is one of the most frequent subtypes of non-Hodgkin lymphomas. We used artificial neural networks (multilayer perceptron and radial basis function), machine learning, and conventional bioinformatics to predict th...

(This article belongs to the Special Issue Medical Imaging and Machine Learning​)
  • Article
  • Open Access
5 Citations
3,732 Views
12 Pages

20 December 2021

Acute kidney injury (AKI) complicates the dosing strategies of oxaliplatin (L-OHP) and the requirement for L-OHP dose reduction in patients with renal failure remains controversial. The objective of this study is to assess the impact of AKI on the ph...

(This article belongs to the Special Issue Pharmacokinetics/Pharmacodynamics/Pharmacogenetics Based Personalized Medicine for Cancer Therapy)
  • Editorial
  • Open Access
2,974 Views
2 Pages

20 December 2021

Over the past 40 years, strategies to treat neoplastic spread into the peritoneal space have benefitted from a gradually evolving approach, thanks mainly to studies conducted by the charismatic leader in this medical field Professor Paul Sugarbaker,...

(This article belongs to the Special Issue Peritoneal Surface Malignancies (PSM): The SICO (Italian Society of Surgical Oncology) PSM—Oncoteam Experience, Result Analysis, and Studies’ Purpose)
  • Review
  • Open Access
15 Citations
4,929 Views
19 Pages

Insights of RKIP-Derived Suppression of Prostate Cancer

  • Ying Dong,
  • Xiaozeng Lin,
  • Anil Kapoor,
  • Yan Gu and ,
  • Hui Xu,
  • Pierre Major and
  • Damu Tang
  • + 2 authors+ 0 author

20 December 2021

Prostate cancer (PC) is a major cause of cancer death in men. The disease has a great disparity in prognosis. Although low grade PCs with Gleason scores ≤ 6 are indolent, high-risk PCs are likely to relapse and metastasize. The standard of care fo...

(This article belongs to the Special Issue RKIP: A Pivotal Gene Product in the Pathogenesis of Cancer)
  • Article
  • Open Access
18 Citations
5,647 Views
15 Pages

Deep Phenotypic Characterisation of CTCs by Combination of Microfluidic Isolation (IsoFlux) and Imaging Flow Cytometry (ImageStream)

  • Antonio J. Ruiz-Rodríguez,
  • Maria P. Molina-Vallejo,
  • Inés Aznar-Peralta,
  • Cristina González Puga and ,
  • Inés Cañas García,
  • Encarna González,
  • Jose A. Lorente,
  • M. Jose Serrano and
  • M. Carmen Garrido-Navas
  • + 4 authors+ 0 author

20 December 2021

The isolation of circulating tumour cells (CTCs) in colorectal cancer (CRC) mostly relies on the expression of epithelial markers such as EpCAM, and phenotypic characterisation is usually performed under fluorescence microscopy with only one or two a...

(This article belongs to the Special Issue Strategies for Isolation and Phenotypic, Genetic, and Functional Characterization of Circulating Tumor Cells)
  • Article
  • Open Access
20 Citations
5,110 Views
17 Pages

Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice

  • Morgane M. Thibaut,
  • Justine Gillard,
  • Adeline Dolly,
  • Martin Roumain and ,
  • Isabelle A. Leclercq,
  • Nathalie M. Delzenne,
  • Giulio G. Muccioli and
  • Laure B. Bindels
  • + 3 authors+ 0 author

20 December 2021

Bile acids exert diverse actions on host metabolism and immunity through bile acid-activated receptors, including Takeda G protein-coupled receptor 5 (TGR5). We have recently evidenced an alteration in bile acids in cancer cachexia, an inflammatory a...

(This article belongs to the Special Issue Cancer-Associated Cachexia)
  • Article
  • Open Access
26 Citations
4,689 Views
12 Pages

20 December 2021

Uveal Melanoma (UM) is a rare disease; however, it is the most common primary intraocular malignant tumor in adults. Hematogenous metastasis, occurring in up to 50% of cases, mainly to the liver (90%), is associated with poor clinical course and trea...

(This article belongs to the Special Issue Advances in the Treatment of Metastatic Uveal Melanoma)
  • Article
  • Open Access
29 Citations
5,455 Views
15 Pages

Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment

  • Sai Preethi Nakkina,
  • Sarah B. Gitto,
  • Veethika Pandey,
  • Jignesh G. Parikh and ,
  • Dirk Geerts,
  • Hans Carlo Maurer,
  • Kenneth P. Olive,
  • Otto Phanstiel and
  • Deborah A. Altomare
  • + 4 authors+ 0 author

20 December 2021

Pancreatic cancer is the fourth leading cause of cancer death. Existing therapies only moderately improve pancreatic ductal adenocarcinoma (PDAC) patient prognosis. The present study investigates the importance of the polyamine metabolism in the panc...

(This article belongs to the Special Issue Tumor Microenvironment of Pancreatic Cancer)
  • Article
  • Open Access
40 Citations
6,525 Views
22 Pages

Cobaltabis(dicarbollide) ([o-COSAN]−) as Multifunctional Chemotherapeutics: A Prospective Application in Boron Neutron Capture Therapy (BNCT) for Glioblastoma

  • Miquel Nuez-Martinez,
  • Catarina I. G. Pinto,
  • Joana F. Guerreiro,
  • Filipa Mendes and ,
  • Fernanda Marques,
  • Amanda Muñoz-Juan,
  • Jewel Ann Maria Xavier,
  • Anna Laromaine,
  • Valeria Bitonto and
  • Clara Viñas
  • + 8 authors+ 3 authors

19 December 2021

Purpose: The aim of our study was to assess if the sodium salt of cobaltabis(dicarbollide) and its di-iodinated derivative (Na[o-COSAN] and Na[8,8′-I2-o-COSAN]) could be promising agents for dual anti-cancer treatment (chemotherapy + BNCT) for...

(This article belongs to the Special Issue Feature Paper from Journal Reviewers)
  • Review
  • Open Access
20 Citations
5,034 Views
16 Pages

Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures

  • Roberto Luigi Cazzato,
  • Fabrice Hubelé,
  • Pierre De Marini,
  • Eric Ouvrard and ,
  • Julien Salvadori,
  • Pietro Addeo,
  • Julien Garnon,
  • Jean-Emmanuel Kurtz,
  • Michel Greget and
  • Alessio Imperiale
  • + 8 authors+ 3 authors

19 December 2021

Neuroendocrine neoplasms (NENs) are rare and heterogeneous epithelial tumors most commonly arising from the gastroenteropancreatic (GEP) system. GEP-NENs account for approximately 60% of all NENs, and the small intestine and pancreas represent two mo...

(This article belongs to the Collection Neuroendocrine Tumors: Treatment and Management)
  • Article
  • Open Access
7 Citations
4,366 Views
18 Pages

CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways

  • Giulia Gallerani,
  • Tania Rossi,
  • Martina Valgiusti,
  • Davide Angeli and ,
  • Pietro Fici,
  • Sara De Fanti,
  • Erika Bandini,
  • Claudia Cocchi,
  • Giovanni Luca Frassineti and
  • Francesco Fabbri
  • + 6 authors+ 1 author

19 December 2021

Background: Here, we monitored the evolution of CTCs spread in 11 patients affected by locally advanced EC who were undergoing therapy. Methods: In this perspective study, we designed multiple blood biopsies from individual patients: before and after...

(This article belongs to the Collection Malignant and Non-malignant Atypical Circulating Cell in Cancer: Their Heterogeneity and Plasticity)
  • Article
  • Open Access
22 Citations
5,396 Views
19 Pages

Efficacy of Superselective Conventional Transarterial Chemoembolization Using Guidance Software for Hepatocellular Carcinoma within Three Lesions Smaller Than 3 cm

  • Shiro Miyayama,
  • Masashi Yamashiro,
  • Rie Ikeda,
  • Junichi Matsumoto and ,
  • Kiyotaka Takeuchi,
  • Naoko Sakuragawa,
  • Teruyuki Ueda,
  • Taku Sanada,
  • Kazuo Notsumata and
  • Takuro Terada
  • + 5 authors+ 0 author

19 December 2021

The indication of transarterial chemoembolization (TACE) has advanced to hepatocellular carcinoma (HCC) of Barcelona Clinic Liver Cancer (BCLC) stage A when surgical resection (SR), thermal ablation, and bridging to transplantation are contraindicate...

(This article belongs to the Collection Novel Therapies for Hepatocellular Carcinoma)
  • Article
  • Open Access
18 Citations
4,080 Views
14 Pages

Health-Related Quality of Life and Return to Work after Surgery for Spinal Meningioma: A Population-Based Cohort Study

  • Jenny Pettersson-Segerlind,
  • Ann-Christin von Vogelsang,
  • Alexander Fletcher-Sandersjöö,
  • Charles Tatter and ,
  • Tiit Mathiesen,
  • Erik Edström and
  • Adrian Elmi-Terander
  • + 2 authors+ 0 author

19 December 2021

Spinal meningiomas are the most common primary spinal intradural tumor. This study aimed to assess Health-related quality of life (HRQoL) and the frequency of return to work in patients surgically treated for spinal meningiomas, in comparison to the...

(This article belongs to the Special Issue Meningioma Surgery and Functional Outcome)
  • Article
  • Open Access
8 Citations
4,423 Views
15 Pages

Transcriptome Analysis in Vulvar Squamous Cell Cancer

  • Katharina Prieske,
  • Malik Alawi,
  • Anna Jaeger,
  • Maximilian Christian Wankner and ,
  • Kathrin Eylmann,
  • Susanne Reuter,
  • Patrick Lebok,
  • Eike Burandt,
  • Niclas C. Blessin and
  • Linn Woelber
  • + 8 authors+ 3 authors

19 December 2021

To date, therapeutic strategies in vulvar squamous cell carcinoma (VSCC) are lacking molecular pathological information and targeted therapy hasn’t been approved in the treatment of VSCC, yet. Two etiological pathways are widely accepted: HPV i...

(This article belongs to the Special Issue Recent Advances in Vulvar Cancer)
  • Article
  • Open Access
35 Citations
5,423 Views
19 Pages

The Vulvar Immunohistochemical Panel (VIP) Project: Molecular Profiles of Vulvar Squamous Cell Carcinoma

  • Giorgia Garganese,
  • Frediano Inzani,
  • Simona Maria Fragomeni,
  • Giulia Mantovani and ,
  • Luigi Della Corte,
  • Alessia Piermattei,
  • Angela Santoro,
  • Giuseppe Angelico,
  • Luciano Giacò and
  • Giovanni Scambia
  • + 8 authors+ 3 authors

19 December 2021

Introduction: The study’s aim was to investigate the immunohistochemical (IHC) expression of biological markers as potential prognostic/therapeutic factors in vulvar squamous cell carcinoma (VSCC). Methodology: A series of 101 patients surgical...

(This article belongs to the Special Issue Recent Advances in Vulvar Cancer)
  • Review
  • Open Access
9 Citations
5,292 Views
13 Pages

19 December 2021

One-fourth of all patients with metastatic non-small cell lung cancer presents with a limited number of metastases and relatively low systemic tumor burden. This oligometastatic state with limited systemic tumor burden may be associated with remarkab...

(This article belongs to the Special Issue Current Management of Oligometastatic Lung Cancer and Future Perspectives)
  • Article
  • Open Access
9 Citations
11,316 Views
20 Pages

Influence of Estrogen Treatment on ESR1+ and ESR1− Cells in ER+ Breast Cancer: Insights from Single-Cell Analysis of Patient-Derived Xenograft Models

  • Hitomi Mori,
  • Kohei Saeki,
  • Gregory Chang,
  • Jinhui Wang and ,
  • Xiwei Wu,
  • Pei-Yin Hsu,
  • Noriko Kanaya,
  • Xiaoqiang Wang,
  • George Somlo and
  • Shiuan Chen
  • + 7 authors+ 2 authors

19 December 2021

A 100% ER positivity is not required for an endocrine therapy response. Furthermore, while estrogen typically promotes the progression of hormone-dependent breast cancer via the activation of estrogen receptor (ER)-α, estrogen-induced tumor sup...

(This article belongs to the Section Cancer Survivorship and Quality of Life)
  • Review
  • Open Access
17 Citations
5,384 Views
15 Pages

18 December 2021

Background: The objective of the present study was to review the essential knowledge about the combinations of the most commonly used or under development targeted treatments and radiation therapy (RT). Methods: Preclinical and clinical studies inves...

(This article belongs to the Special Issue Breast Cancer Radiotherapy: The State of the Art)
  • Article
  • Open Access
6 Citations
4,027 Views
12 Pages

D-Mannose Slows Glioma Growth by Modulating Myeloperoxidase Activity

  • Negin Jalali Motlagh,
  • Cuihua Wang,
  • Enrico Giovanni Kuellenberg,
  • Gregory R. Wojtkiewicz and ,
  • Stephan Schmidt and
  • John W. Chen
  • + 1 author+ 0 author

18 December 2021

Host immune response in the tumor microenvironment plays key roles in tumorigenesis. We hypothesized that D-mannose, a simple sugar with anti-inflammatory properties, could decrease oxidative stress and slow glioma progression. Using a glioma stem ce...

  • Opinion
  • Open Access
17 Citations
7,086 Views
14 Pages

Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer

  • Francesco Sclafani,
  • Claudia Corrò and
  • Thibaud Koessler

18 December 2021

Recently, two large, randomised phase III clinical trials of total neoadjuvant therapy (TNT) in locally advanced rectal cancer were published (RAPIDO and PRODIGE 23). These two trials compared short-course radiotherapy (SCRT) followed by chemotherapy...

(This article belongs to the Special Issue Current Management of Early and Advanced Rectal Cancer)
  • Article
  • Open Access
9 Citations
6,728 Views
19 Pages

β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreatic Ductal Adenocarcinoma

  • Michael F. Coleman,
  • Kristyn A. Liu,
  • Alexander J. Pfeil,
  • Suhas K. Etigunta and ,
  • Xiaohu Tang,
  • Salvador Fabela,
  • Laura M. Lashinger,
  • Zhengrong Cui and
  • Stephen D. Hursting
  • + 4 authors+ 0 author

18 December 2021

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths in the United States, and effective therapies for PDAC are currently lacking. Moreover, PDAC is promoted and exacerbated by obesity, while cachexia and sarco...

(This article belongs to the Special Issue Novel Metabolic Approaches Targeting Cancer Cells)
  • Article
  • Open Access
27 Citations
4,074 Views
21 Pages

Blood Bacterial DNA Load and Profiling Differ in Colorectal Cancer Patients Compared to Tumor-Free Controls

  • Massimiliano Mutignani,
  • Roberto Penagini,
  • Giorgio Gargari,
  • Simone Guglielmetti and ,
  • Marcello Cintolo,
  • Aldo Airoldi,
  • Pierfrancesco Leone,
  • Pietro Carnevali,
  • Clorinda Ciafardini and
  • Marta Rossi
  • + 28 authors+ 23 authors

18 December 2021

Inflammation and immunity are linked to intestinal adenoma (IA) and colorectal cancer (CRC) development. The gut microbiota is associated with CRC risk. Epithelial barrier dysfunction can occur, possibly leading to increased intestinal permeability i...

  • Article
  • Open Access
29 Citations
4,284 Views
8 Pages

Sequential Isolation and Characterization of Single CTCs and Large CTC Clusters in Metastatic Colorectal Cancer Patients

  • Federica Francescangeli,
  • Valentina Magri,
  • Maria Laura De Angelis,
  • Gianluigi De Renzi and ,
  • Orietta Gandini,
  • Ann Zeuner,
  • Paola Gazzaniga and
  • Chiara Nicolazzo
  • + 3 authors+ 0 author

18 December 2021

Circulating tumor cells (CTCs) detach from a primary tumor or its metastases and circulate in the bloodstream. The vast majority of CTCs are deemed to die into the bloodstream, with only few cells representing viable metastatic precursors. Particular...

(This article belongs to the Special Issue In Vitro and In Vivo Models of Colorectal Cancer for Clinical Application)
  • Review
  • Open Access
19 Citations
4,721 Views
13 Pages

The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping Review

  • Amy L. Shaver,
  • Swapnil Sharma,
  • Nikita Nikita,
  • Daniel S. Lefler and ,
  • Atrayee Basu-Mallick,
  • Jennifer M. Johnson,
  • Meghan Butryn and
  • Grace Lu-Yao
  • + 3 authors+ 0 author

18 December 2021

Background: Cancer therapies are associated with multiple adverse effects, including (but not limited to) cancer-related fatigue (CRF). Fatigue is one of the most common side effects of immune checkpoint inhibitors (ICIs), occurring in up to 25% of p...

(This article belongs to the Special Issue Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?)
  • Review
  • Open Access
18 Citations
8,154 Views
22 Pages

18 December 2021

The disaccharide lactose is an excipient commonly used in pharmaceutical products. The two anomers, α- and β-lactose (α-L/β-L), differ by the orientation of the C-1 hydroxyl group on the glucose unit. In aqueous solution, a muta...

(This article belongs to the Special Issue New Targets and Therapies of Acute Myeloid Leukemia)
  • Systematic Review
  • Open Access
25 Citations
5,879 Views
19 Pages

Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review

  • Joosje C. Baltussen,
  • Marij J. P. Welters,
  • Elizabeth M. E. Verdegaal,
  • Ellen Kapiteijn and ,
  • Anne M. R. Schrader,
  • Marije Slingerland,
  • Gerrit-Jan Liefers,
  • Sjoerd H. van der Burg,
  • Johanneke E. A. Portielje and
  • Nienke A. de Glas
  • + 5 authors+ 0 author

18 December 2021

Immune checkpoint inhibitors (ICIs) have strongly improved the survival of melanoma patients. However, as durable response to ICIs are only seen in a minority, there is an unmet need to identify biomarkers that predict response. Therefore, we provide...

(This article belongs to the Section Systematic Review or Meta-Analysis in Cancer Research)
  • Review
  • Open Access
13 Citations
5,107 Views
20 Pages

Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System

  • Manuel Montesinos-Rongen,
  • Anna Brunn,
  • Monica Sanchez-Ruiz,
  • Ralf Küppers and ,
  • Reiner Siebert and
  • Martina Deckert
  • + 1 author+ 0 author

17 December 2021

Primary lymphoma of the central nervous system (PCNSL, CNS) is a specific diffuse large B cell lymphoma (DLBCL) entity confined to the CNS. Key to its pathogenesis is a failure of B cell differentiation and a lack of appropriate control at differenti...

(This article belongs to the Special Issue Primary CNS Lymphomas: Diagnosis and Treatment)
  • Review
  • Open Access
43 Citations
11,630 Views
12 Pages

Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck

  • Carlos A. Rodriguez-Russo,
  • Jacqueline C. Junn,
  • Sue S. Yom and
  • Richard L. Bakst

17 December 2021

Adenoid cystic carcinoma of the head and neck is an uncommon malignancy that can arise in the major or minor salivary glands. Perineural invasion (PNI) is an extremely frequent finding in cases of adenoid cystic carcinoma (ACC) that can be associated...

(This article belongs to the Special Issue Salivary Gland Adenoid Cystic Carcinoma)
  • Article
  • Open Access
32 Citations
4,167 Views
14 Pages

Epilepsy in NF1: Epidemiologic, Genetic, and Clinical Features. A Monocentric Retrospective Study in a Cohort of 784 Patients

  • Ugo Sorrentino,
  • Silvia Bellonzi,
  • Chiara Mozzato,
  • Valeria Brasson and ,
  • Irene Toldo,
  • Raffaele Parrozzani,
  • Maurizio Clementi,
  • Matteo Cassina and
  • Eva Trevisson
  • + 4 authors+ 0 author

17 December 2021

An increased lifetime risk of epilepsy has been reported in neurofibromatosis type 1 (NF1) patients, ranging between 4% and 14%. To further analyze the correlation between NF1 and epilepsy, we retrospectively reviewed the epidemiologic, clinical, rad...

  • Review
  • Open Access
10 Citations
4,646 Views
22 Pages

Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation

  • Marco Biolato,
  • Tiziano Galasso,
  • Giuseppe Marrone,
  • Luca Miele and
  • Antonio Grieco

17 December 2021

In Europe and the United States, approximately 1100 and 1800 liver transplantations, respectively, are performed every year for hepatocellular carcinoma (HCC), compared with an annual incidence of 65,000 and 39,000 new cases, respectively. Because of...

(This article belongs to the Special Issue Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment)
  • Article
  • Open Access
5 Citations
3,455 Views
13 Pages

Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma

  • Fiorella L. Roldán,
  • Juan J. Lozano,
  • Mercedes Ingelmo-Torres,
  • Raquel Carrasco and ,
  • Esther Díaz,
  • Miguel Ramirez-Backhaus,
  • José Rubio,
  • Oscar Reig,
  • Antonio Alcaraz and
  • Laura Izquierdo
  • + 6 authors+ 1 author

17 December 2021

The probability of tumor progression in intermediate/high-risk clear cell renal cell carcinoma (ccRCC) is highly variable, underlining the lack of predictive accuracy of the current clinicopathological factors. To develop an accurate prognostic class...

(This article belongs to the Collection The Biomarkers for the Diagnosis and Prognosis in Cancer)
  • Article
  • Open Access
32 Citations
4,787 Views
13 Pages

Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma

  • Adam Stenman,
  • Minjun Yang,
  • Johan O. Paulsson,
  • Jan Zedenius and ,
  • Kajsa Paulsson and
  • C. Christofer Juhlin
  • + 1 author+ 0 author

17 December 2021

Anaplastic thyroid carcinoma (ATC) is a lethal malignancy characterized by poor response to conventional therapies. Whole-genome sequencing (WGS) analyses of this tumor type are limited, and we therefore interrogated eight ATCs using WGS and RNA sequ...

(This article belongs to the Special Issue Molecular Alterations in Thyroid Cancer – with Special Focus on Diagnosis, Prognosis and Treatment)
  • Review
  • Open Access
16 Citations
5,659 Views
14 Pages

The Roles of Tricellular Tight Junction Protein Angulin-1/Lipolysis-Stimulated Lipoprotein Receptor (LSR) in Endometriosis and Endometrioid-Endometrial Carcinoma

  • Hiroshi Shimada,
  • Takayuki Kohno,
  • Takumi Konno,
  • Tadahi Okada and ,
  • Kimihito Saito,
  • Yuma Shindo,
  • Shin Kikuchi,
  • Mitsuhiro Tsujiwaki,
  • Marie Ogawa and
  • Takashi Kojima
  • + 7 authors+ 2 authors

17 December 2021

Tight junction proteins play roles beyond permeability barriers functions and control cell proliferation and differentiation. The relation between tight junctions and the signal transduction pathways affects cell growth, invasion and migration. Abnor...

(This article belongs to the Special Issue Therapy for Human Endometrioid - Endometrial Carcinoma and Endometriosis)
  • Article
  • Open Access
10 Citations
4,843 Views
14 Pages

Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma

  • Peter Kar Han Lau,
  • Carleen Cullinane,
  • Susan Jackson,
  • Rachael Walker and ,
  • Lorey K. Smith,
  • Alison Slater,
  • Laura Kirby,
  • Riyaben P. Patel,
  • Bianca von Scheidt and
  • Karen E. Sheppard
  • + 7 authors+ 2 authors

17 December 2021

Despite the success of immune checkpoint inhibitors that target cytotoxic lymphocyte antigen-4 (CTLA-4) and programmed-cell-death-1 (PD-1) in the treatment of metastatic melanoma, there is still great need to develop robust options for patients who a...

(This article belongs to the Special Issue Challenges and Opportunities for Effective Cancer Immunotherapies)
  • Article
  • Open Access
12 Citations
3,591 Views
17 Pages

Osteocytic Connexin Hemichannels Modulate Oxidative Bone Microenvironment and Breast Cancer Growth

  • Yi Tian,
  • Manuel A. Riquelme,
  • Chao Tu,
  • Yumeng Quan and ,
  • Xiaowen Liu,
  • Lu-Zhe Sun and
  • Jean X. Jiang
  • + 2 authors+ 0 author

17 December 2021

Osteocytes, the most abundant bone cell types embedded in the mineral matrix, express connexin 43 (Cx43) hemichannels that play important roles in bone remodeling and osteocyte survival. Estrogen deficiency decreases osteocytic Cx43 hemichannel activ...

  • Review
  • Open Access
36 Citations
7,020 Views
23 Pages

New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers

  • Jitka Holcakova,
  • Martin Bartosik,
  • Milan Anton,
  • Lubos Minar and ,
  • Jitka Hausnerova,
  • Marketa Bednarikova,
  • Vit Weinberger and
  • Roman Hrstka
  • + 3 authors+ 0 author

17 December 2021

The prevention and early diagnostics of precancerous stages are key aspects of contemporary oncology. In cervical cancer, well-organized screening and vaccination programs, especially in developed countries, are responsible for the dramatic decline o...

(This article belongs to the Special Issue High Risk Gynecological Cancers)
  • Article
  • Open Access
18 Citations
4,018 Views
13 Pages

Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer

  • Ji Hyun Lee,
  • Byul A Jee,
  • Jae-Hun Kim,
  • Hoyoung Bae and ,
  • Jae Hoon Chung,
  • Wan Song,
  • Hyun Hwan Sung,
  • Hwang Gyun Jeon,
  • Byong Chang Jeong and
  • Minyong Kang
  • + 9 authors+ 4 authors

17 December 2021

The clinical value of sarcopenia has not been determined yet in metastatic hormone-sensitive prostate cancer (mHSPC). We retrospectively evaluated data of 70 consecutive patients with mHSPC receiving treatment with either early docetaxel (n = 42) or...

(This article belongs to the Collection Imaging Biomarker in Oncology)
  • Article
  • Open Access
9 Citations
4,442 Views
18 Pages

SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase

  • Youcef Ounoughene,
  • Elise Fourgous,
  • Yvan Boublik,
  • Estelle Saland and ,
  • Nathan Guiraud,
  • Christian Recher,
  • Serge Urbach,
  • Philippe Fort,
  • Jean-Emmanuel Sarry and
  • Serge Roche
  • + 6 authors+ 1 author

17 December 2021

The PEAK1 and Pragmin/PEAK2 pseudo-kinases have emerged as important components of the protein tyrosine kinase pathway implicated in cancer progression. They can signal using a scaffolding mechanism that involves a conserved split helical dimerizatio...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
10 Citations
5,170 Views
16 Pages

Expression of Endogenous Retroviral RNA in Prostate Tumors has Prognostic Value and Shows Differences among Americans of African Versus European/Middle Eastern Ancestry

  • Vinay Kumar,
  • Michael McClelland,
  • James Nguyen,
  • Gabriela De Robles and ,
  • Michael Ittmann,
  • Patricia Castro,
  • Dan Mercola,
  • Zhenyu Jia and
  • Farah Rahmatpanah
  • + 4 authors+ 0 author

17 December 2021

Endogenous retroviruses (ERVs) are abundant, repetitive elements dispersed across the human genome and are implicated in various diseases. We investigated two potential roles for ERVs in prostate cancer (PCa). First, the PCa of Black Americans (BA) i...

(This article belongs to the Collection Regulatory and Non-Coding RNAs in Cancer Epigenetic Mechanisms)
  • Article
  • Open Access
4 Citations
3,751 Views
17 Pages

Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients

  • Samrat Roy Choudhury,
  • Cody Ashby,
  • Fenghuang Zhan and
  • Frits van Rhee

17 December 2021

High-risk Multiple Myeloma (MM) patients were found to maintain telomere length (TL), below the margin of short critical length, consistent with proactive overexpression of telomerase. Previously, DNA methylation has been shown as a determinant of te...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
22 Citations
6,529 Views
28 Pages

Side-by-Side Comparison of Five Chelators for 89Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability

  • Helen Damerow,
  • Ralph Hübner,
  • Benedikt Judmann,
  • Ralf Schirrmacher and ,
  • Björn Wängler,
  • Gert Fricker and
  • Carmen Wängler
  • + 2 authors+ 0 author

17 December 2021

In this work, five different chelating agents, namely DFO, CTH-36, DFO*, 3,4,3-(LI-1,2-HOPO) and DOTA-GA, were compared with regard to the relative kinetic inertness of their corresponding 89Zr complexes to evaluate their potential for in vivo applic...

(This article belongs to the Special Issue Recent Trends in PET/CT Tracer Development and Multimodal Imaging)

of 5

XFacebookLinkedIn
Cancers - ISSN 2072-6694